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Developmental programming of the fetus has consequences for physiologic responses in the offspring as an adult
and, more recently, is implicated in the expression of altered phenotypes of future generations. Some phenotypes,
such as fertility, bone strength, and adiposity are highly relevant to food animal production and in utero factors that
impinge on those traits are vital to understand. A key systemic regulatory hormone is growth hormone (GH), which
has a developmental role in virtually all tissues and organs. This review catalogs the impact of GH on tissue
programming and how perturbations early in development influence GH function.
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Broadly considered, development has two distinct yet
interrelated facets: alterations in gene expression associ-
ated with the normal developmental profile of an organ-
ism and alterations associated with developmental
plasticity permitting adaptation to environment pertur-
bations. The fundamental role of normal fetal develop-
ment is best exemplified by pattern formation in the
embryo. “Programming” was a term coined in 1986 to
reflect that events occurring in utero alter adult pheno-
typic and metabolic traits [1]. The influence of fetal and
neonatal nutritional environments on metabolic pro-
gramming was first conceptualized by Lucas [2] and the
concept of developmental programming was later ex-
panded to include other environmental perturbations
[3,4]. The impact of environmental challenges experienced
in the neonatal period emphasizes the need to understand
both inherent development as well as the mechanistic pro-
cesses by which developmental programming is achieved.
Recent data highlight that the metabolic environment
experienced by the fetus influences phenotypic expres-
sion and disease susceptibility in later life [5,6]. Small for
gestational age (SGA) offspring, often arising as a conse-
quence of malnourished mothers, is correlated with adult
hypertension, glucose intolerance, insulin resistance, type
2 diabetes, dyslipidemia, and diminished measures of boneCorrespondence: amoberbauer@ucdavis.edu
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unless otherwise stated.strength. Metabolic bone disease is also associated with
prenatal nutrient deprivation [7]. Adult-onset disorders
associated with SGA neonates represent programming oc-
curring at the gene level by methylation, gene silencing,
and other epigenetic modifications established during fetal
development (reviewed in [8]). It is worth noting that the
definition of epigenetics used in this review is “the struc-
tural adaptation of chromosomal regions so as to register,
signal or perpetuate altered activity states” first proposed
by Bird in 2007 to encompass the many aspects of epigen-
etic alterations [9].
Although not developmental programming, the most
familiar illustration of developmental epigenetic imprint-
ing is the insulin-like growth factor-2 (IGF-2) pathway.
The methylation status differs between the paternally
and maternally inherited Igf-2 gene with the paternal
copy as the sole source of IGF-2 during development
and the maternally inherited copy silenced. It is hypothe-
sized that the maternal and paternal expression are
balanced to maximally promote fetal growth while pre-
venting excessive depletion of the dam’s resources [10].
Another example of the role of epigenetic imprinting oc-
curs in Prader-Willi Syndrome, a syndrome character-
ized by growth hormone (GH) insufficiency [11]. The
genetic cause is the deletions of paternal chromosome
15; the maternal region is silenced by epigenetic factors.
While IGF-2’s role is predominantly in prenatal develop-
ment, the key postnatal hormone is GH. Growth hor-
mone effects are either direct or mediated through thehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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through its effects on adipose, bone, and muscle, is
growth hormone (GH) [13].
Importantly, developmental programming may have
multigenerational consequences transmitted through epi-
genetic modifications of the genome. Transgenerational
epigenetic programming was initially recognized as a re-
sult of malnourishment. The Dutch famine, sometimes re-
ferred to as the “Hunger winter”, is most often cited as the
initial epidemiological human case study illustrating the
impacts of nutritional stress upon both physical and be-
havioral traits in subsequent generations (reviewed in
[14]). More recent evidence of transgenerational conse-
quences has been associated with environmental perturba-
tions including toxicants and hormonal manipulations
[15-17]. Although many effects are termed “transgenera-
tional,” Heard and Martienssen [18] recommend a more
parsimonious use of the term and define much of what
has been observed as “intergenerational” which will be
employed in this review. Nevertheless, understanding
the link between fetal and neonatal programming and
subsequent phenotypic expression is important for hu-
man health and has value for sustainable food animal
production systems. Nutritional, physical, and psycho-
logical stress experienced by livestock influences imme-
diate productivity and health [19-21] and yet notably
can also affect future generations’ production through
developmental programming.
Review
Role of GH in normal development
The accepted role of GH and the GH-IGF axis in tissue
development is predominantly postnatal with other hor-
mones assuming importance in utero [5]. Yet GH is
known to influence fetal development. For example, trans-
genic mice overexpressing GH, produce offspring with a
12% reduction in birth weight [22] and calves born to
dams given exogenous bovine somatotropin (GH) have
reduced birth weights [23,24]. These findings indicate that
GH, or its downstream regulators, plays a significant role
in normal fetal development. The intimate link between
GH and generalized growth has led to the speculation
that GH may also affect the expression of IGF-2 though
the evidence does not support this supposition to any
great extent [25].
Evidence that fetal perturbations program GH signal-
ing is also emerging. A common model used to define
the role of GH in developmental programming is the
neonate that experienced impaired fetal growth, specific-
ally SGA infants, who are characterized by compromised
bone growth and reduced body mass. Infants having low
birth weights trend to lower circulating GH as young
adults [26] indicating persistent effects by early develop-
mental experiences on GH secretion. Despite prenatalgrowth impairment, approximately 90% of SGA births
have accelerated growth in the first two postnatal years
achieving heights in the normal range [27,28]; however
the remaining 10% do not exhibit catch-up growth giv-
ing evidence of fetal programming of the GH-IGF endo-
crine axis as a consequence of early growth dysfunction
[29]. Also associated with SGA is reduced bone mass
and strength in adulthood [30] indicative of develop-
mental programming of bone remodeling. GH, with its
role in bone mineral density [31], may mediate the adult
bone characteristics arising from in utero growth restric-
tion. Furthermore, adult height is correlated with placental
GH expression. Genetic variation within the sequence of
the placental-form of GH is significantly associated with
mature height confirming that altered expression of GH
in utero governs longitudinal bone growth potential [32].
Immune function is depressed chronically in SGA rat
pups, although the condition can be reversed by provision
of exogenous GH during the pre-weaning growth stage
[33] indicating GH is important in the ontogeny of im-
mune competence.
Birth weight and neonatal growth is predictive of adult
circulating GH levels suggesting that the intrauterine
environment programs GH secretion [34] or tissue re-
sponsiveness to GH. Waldman and Chia postulate that
idiopathic short stature reflects epigenetic changes to
the GH receptor or to IGF-1 genes [35]. Research ex-
ploring the chromatin landscape suggests a tissue speci-
ficity in the accessiblity of the IGF-1 promoter indicating
epigenetic regulation of the GH-IGF-1 axis [36,37]. This
view is supported by developmental profiling of IGF-1
mRNA expression in cattle; as female calves mature, IGF-
1 gene expression in the pituitary is reduced, particularly
the exon most responsive to GH, whereas IGF-1 expres-
sion in the uterus increased [38].
Elevated GH models
In utero exposure
The role of GH in normal development was established
decades ago through ablation studies and assessing the
physiological consequences of the absence of GH. Add-
itional models to characterize GH action elevate the hor-
mone either through exogenous administration of GH,
GH-transgene expression, or chemical compounds that
induce GH. Elevated GH in utero reduces birth weights
of calves [23], lambs [39], and rodents [22]. In sheep,
fetal adipogenesis is enhanced when dams are exposed
to GH indicating the direct effect of GH on adipose me-
tabolism [39]. For rodent models, neonates are both
lighter in weight and have reduced skeletal size at birth.
In contrast, pregnant sows given hydroxyl beta methyl-
butyrate (HMB), a compound that enhances fetal GH
and IGF-1, give birth to piglets with increased birth
weights [40]. Furthermore, the piglet data indicate that
Oberbauer Journal of Animal Science and Biotechnology  (2015) 6:8 Page 3 of 7fetal exposure to elevated GH has persistent effects on
growth parameters into adulthood; they had increased
growth rate to slaughter, lean carcass content and indi-
ces of bone strength [40]. Similar to the rodents, piglets
from HMB treated sows had shorter femurs although in
a different study, provision of GH directly to pregnant
sows did not affect bone length in the neonates [41].
Ewes treated with extended -release GH during gestation
delivered lambs having heavier birth weights and a sus-
tained postnatal growth advantage over lambs born of
untreated ewes as well as a blunted response to stimula-
tion of the GH axis [42,43]. Taken together, the evidence
suggests that exposure to elevated GH in utero exerts
long term consequences on the offspring possibly
through alteration of maternal metabolic pathways and
placental function.
Postnatal exposure
Elevated GH postnatally has significant effects on bone,
muscle, and adipose. Human SGA infants given GH re-
spond with increased bone growth velocity for the dur-
ation of GH treatment [8]. In rodents, provision of GH
during the postnatal period can reverse the in utero
growth inhibition and restore overall bone length [22].
GH exerts stimulatory effects on linear growth rates in
rodents with transient elevation of GH increasing bone
growth rate. At the cellular level, GH accelerates bone
growth by hyperplasia with little impact on hypertrophy
[44]. Provision of elevated GH in a GH-transgenic mouse
model also increases the duration of bone elongation
though the degree of responsiveness is sensitive to the
chronological age of exposure with early neonatal tissue
more responsive than slightly older ages.
Lambs given HMB during the first 3 postnatal weeks
show elevated circulating levels of GH, IGF-1, and bio-
chemical markers of bone turnover. However once the
HMB treatment concludes, these indices all fall to con-
trol values indicating resistance to long term bone pro-
gramming by HMB when provided postnatally [45]. The
failure of persistent HMB treatment effects in lambs, in
contrast to the direct GH effects seen in rodents and
pigs, may reflect the precocial development of sheep
when compared to that of rodents and pigs suggesting
that the period responsive to GH programming may be
in utero for lambs.
The enhanced gain accompanying elevated GH has a
greater proportion of protein than normal tissue accrual
in rodents. Rodent development is characterized by each
unit of gain being composed of the same proportions of
water, lipid, protein and ash across the entire growth
phase, despite the speed of accrual [46]. In contrast,
under conditions of elevated GH, protein comprises a
larger proportion of gain [47]. This preferential reparti-
tioning by GH of nutrients to muscle is also seen in pigstransgenic for GH [48], broilers supplemented with HMB
[49], fish given exogenous GH [50], and GH-transgenic
fish [51]. Exogenous GH increases protein anabolism by
enhancing protein synthesis [52,53].
Therapeutic GH treatment of SGA children offers
growth advantages as noted above, yet the elevated GH
also reduces insulin sensitivity potentially increasing the
risk of diabetes. Recent studies of children born SGA
and treated with GH would suggest this is not a valid
concern as they have normal insulin post-GH treatment
[8]. However, these children have not aged to a point
wherein the long term consequences of GH treatment
can be evaluated; thus, adult onset diabetes remains a
concern. In a rodent model, elevating GH in adult mice
increases circulating insulin with levels remaining ele-
vated even after reduction of GH consistent with an in-
sulin resistant state, though persistence of this condition
was not determined [54].
The role of GH in adipogenesis is complex. In utero or
postnatal exposure to elevated GH in a GH-transgenic
mouse model increases adipose storage by increasing
adipocyte hyperplasia, differentiation, and cellular lipid
content [39,54,55]. Artificially elevating GH induces lipo-
protein lipase which in turn stimulates adipogenesis; the
elevated GH also increases circulating insulin which then
can induce lipoprotein lipase further promoting adipose
storage [56]. Postnatal exposure to GH acts on membrane
lipids to program response to cellular perturbations. Ele-
vated GH in rodents creates a more unsaturated lipid pro-
file in cell membranes by activating membrane desaturase
pathways [57]. This net flux through the lipid metabolism
pathways generates eicosanoids important in the inflam-
mation process [58].
The interplay with leptin adds more complexity to the
influence of GH on adipose. Leptin, synthesized by adi-
pose cells, regulates energy metabolism (reviewed in [59])
and influences fetal brain and bone development [60].
Leptin also defines energy storage adequacy during neo-
natal life and can program the neuronal regulation of adult
food intake and satiety with leptin programming in early
development altering adiposity at later ages [61,62]. New-
born rodents and piglets born SGA experience adipogene-
sis however neonatal provision of exogenous leptin can
reverse the adipocyte proliferation induced by intrauterine
growth restriction [61,63]. Leptin levels correlate with
birth weight with SGA infants having low leptin levels
while large for gestational age babies have high leptin con-
centrations [64]. Although the correlation is largely inde-
pendent of the GH-IGF-1 axis (reviewed by [62]), GH
levels influence maternal and fetal leptin levels. In sheep,
fetal adipogenesis is enhanced when dams are exposed to
GH and leptin levels are reduced in the dam and the fetus,
demonstrating a direct effect of GH on adipose in utero
[39] with potential of long term programming impacts.
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in turn elevates leptin that influences adipose function at
later ages. Elevated GH in a GH-transgenic mouse model
increases plasma leptin [65] while mice transiently ex-
posed to elevated GH during early postnatal development
become obese having increased circulating leptin once the
excess GH is withdrawn [54]. In these GH-transgenic
mice, although each adipocyte expresses less leptin, the
leptin in circulation is greater due to the increased over-
all adipocity. This suggests that prolonged elevation of
GH disrupts normal physiological responses to elevated
plasma leptin, creating leptin resistance and obesity; in
the case of elevated GH, the most likely site of leptin
signaling impairment is at the hypothalamic axis. Sup-
porting this view of GH generating leptin resistance is
that the elevated GH in the GH- transgenic mouse in-
creases plasma leptin as well as the leptin receptor
(NPY) gene and protein expression [65]. It is proposed
that leptin resistance can be programmed during fetal
and neonatal life with long term impacts on body energy
stores potentiating adult onset metabolic disorders [63].
Models of in utero programming
Studies in multiple mammalian species demonstrate that
aberrant programming of adult tissue response is associ-
ated with stress-induced glucocorticoid secretion during
fetal and perinatal development. Maternal stress in
humans is known to impact neurological circuitry of the
offspring: infants have an increased risk of neuropsychi-
atric disease when the mother experienced psychological
stress during the first trimester (reviewed in [66]).
Similarly, prospective stress research with rodents and
non-human primates have identified gestational periods
of increased susceptibility to developmental disruption
[66]. Importantly the maternal stress response is charac-
terized by altered methylation patterns in the fetal DNA
[67] thereby programming future gene expression pat-
terns that may also be transmitted to the next gener-
ation. Similar changes in methylation patterns have been
detected in response to maternal exposure to toxins and
hormones [68] resulting in intergenerational epigenetic
changes having significant impact on future physio-
logical performance and significant implications on se-
lection for production species.
Early research demonstrated that adult GH secretory
patterns are influenced by perturbations during the peri-
natal period. For example, male rats normally express a
high amplitude secretory pattern of GH whereas females
have low amplitude pulses within a higher basal back-
ground. Transient manipulation of sex steroids in the
neonatal period can modify the GH secretory pattern to
that of the opposite sex [69]. Glucocorticoids are viewed
as critical modulators of GH in a wide range of species
including chickens, rodents, and humans with impactson the hypothalamus and pituitary regulation of GH re-
lease, somatotrope development, and peripheral tissue
responsivity [70-74]. In turn, GH mediates gene regula-
tion by increasing accessibility of the transcriptional ma-
chinery by chromatin remodeling of promoters through
histone acetylation [36]. Taken together, stress has pro-
found impacts on the development of the neonate that
may transcend a single generation and GH plays a role
in programming the consequences of the stress.
Nutritional stress
Mothers who are undernourished during pregnancy give
birth to SGA infants and when adult those children
exhibit adult-onset obesity, insulin resistance, hyperten-
sion, and metabolic dysfunction. Maternal nutritional
deprivation stress also is implicated in intergenerational
epigenetic programming to alter future generations’ growth
and metabolic phenotypes. This phenomenon is suggested
to account for the rising cases of human obesity, diabetes,
and coronary disease (reviewed in [66]).
Levels of placental GH found in maternal circulation
are positively correlated with fetal birth weight and in
times of maternal nutrient deprivation and SGA preg-
nancies, placental GH secretion is reduced [32]. A recent
study of ewes undernourished during gestation reported
that although maternal circulating GH and placental
weight were not reduced [75], birth weights and crown
rump lengths were [76]. Newbern and Freemark [77] re-
view the evidence that supports a direct role of GH and
placental GH in the programming of fetal growth and
long-term metabolic function. Some evidence is based
upon transgenic mice that overexpress placental GH
and their high birth weight pups with enhanced growth
capacity relative to their non-transgenic littermates [78].
As noted above, there are generalized consequences of
SGA on bone characteristics but SGA due to nutritional
deprivation also programs bone through the GH- IGF
axis. The necessity of adequate fetal and neonatal nutri-
tion for normal bone growth and adult bone integrity
was underscored by Eastell and Lambert in their review
[79]. In rats, post-weaning dietary protein restriction al-
ters the GH secretory profile, blunting the peak GH
pulses [80] which alters growth and metabolic responses.
It is known that neonatal nutrition programs adult bone
mass [81] and bone density is positively associated with
peak GH and IGF-1 concentrations but elevated median
GH concentrations, as seen with dietary restriction, is
negatively associated with bone density [34]. Presumably
the effects on bone are due to the role that GH plays in
opening the chromatin surrounding the IGF-1 gene. More-
over, maternal malnutrition alters methylation of the GH
responsive promoter 2 of the IGF-1 gene (reviewed in [12])
and intrauterine growth restriction is associated with
sustained hypermethlyation of the IGF-1 promoter in
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GH in the neonate.
Another mechanism of nutritional programming on
bone is by its effects on the formation of the embryonic
skeletal anlage. Fetal and postnatal bone growth depends
upon chondrocyte hypertrophy and hyperplasia. Fibroblast
growth factors (FGF) and their cognate fibroblast growth
factor receptors (FGFR) are key signaling molecules of
chondrocyte function in developing bone. Activation of
different FGFR family members both promote and inhibit
chondrocyte proliferation [83]. The FGF21 ligand directly
inhibits chondrocyte proliferation and antagonizes the
proliferative effects of GH on growth plate chondrocytes
[84] thereby impairing chondrogenesis and bone growth.
FGF21 is increased during food restriction and attenuates
the action of GH at the chondrocytic level and at the
systemic level by impairing IGF-1 expression [84]. Antag-
onizing GH action by elevated FGF as result of food re-
striction has implications for many of the body systems
because of GH’s extensive broad range of target tissues.
In rats, restricting maternal dietary protein to induce
intrauterine growth restriction enlarges abdominal adipose
depots when animals are adult [85]. The enlarged adipose
depots upregulate expression of genes associated with en-
hanced lipid metabolism and adipose accrual. Provision of
exogenous GH postnatally can minimize those adult con-
ditions [33,86]. Specifically, adult-onset obesity seen in
pups born to undernourished rat dams can be prevented
with preweaning GH treatment [87] (reviewed in [88]).
This provides compelling evidence of early GH program-
ming the adult physiological response.
Intrauterine growth restricted babies, piglets, and ro-
dent pups have reduced leptin at birth and then propen-
sity for obesity at adulthood [89]; provision of leptin
reverses this tendency [61]. At birth infants considered
SGA have greater methylation of the leptin promoter
correlating with the reduced circulating leptin levels [90].
In contrast, using a mouse model, early nutritional pro-
gramming of the fetus by low protein diets is correlated
with hypomethylation of the leptin gene that is maintained
throughout life [91]. In the latter study, the authors ac-
knowledge their results differ from the pattern of leptin ex-
pression, and methylation, observed in other species in
response to maternal malnutrition. Adipocyte hypertrophy
results in hypomethylation of the leptin gene and Increases
leptin expression which increases adipose hyperplasia [89].
Clearly the specifics of the nutritional deprivation, timing,
and species evaluated have significant impact on the
manifestation of maternal malnutrition on adult suscep-
tibility to metabolic disruption.
Physical stress
Physical stressors, often modeled with induced hypoxia,
have been used to assess the epigenetic consequences ofstress. Hypoxia-inducible factor 1 (HIF-1), induced under
conditions of hypoxia to adapt to reduced oxygen supply,
is also required for normal fetal tissue and skeletal devel-
opment [92]. The transcription factor HIF-I coordinates
with additional factors to induce chromatin remodeling of
target genes [93]. In addition to the role of HIF-1 in hyp-
oxia adaptation, in rodents the GH axis modulates the
hypoxic stress response [94]. In periods of intermittent
hypoxia, GH is neuroprotective [95]. However, hypoxia el-
evates glucocorticoid expression from the fetal adrenal
gland [96] and elevated glucocorticoids can lead to the
programming of the fetal GH axis as detailed earlier in
this article [73,74]. Furthermore, hypoxia inhibits GH
release by enhancing the expression of somatostatin, the
hypothalamic GH inhibitor [97]. Varvarigou et al [98]
propose that severe hypoxia permanently damages the
fetal hypothalamic-hypophyseal axis leading to greatly
diminished GH secretory profiles. Despite the knowledge
that fetal programming is a consequence of hypoxia, de-
fining the long term and intergenerational effects of phys-
ical stressors are yet to be fully explored.
Conclusions
Growth hormone has a pivotal role in pre and postnatal
development although its effects on intergenerational pro-
gramming are as yet under studied. Given the plasticity of
postnatal development, defining fetal and neonatal pro-
gramming and the effect upon later phenotypes is import-
ant to maximize the expression of desirable traits in food
animals. This is particularly important on the impact of
more permanent epigenetic alterations of gene expression
that may have future consequences. Historically, classical
genetic selection has permitted extremely favorable pheno-
typic advances. The implementation of quantitative trait
loci selection schemes for livestock based upon genomic
signatures will accelerate genetic improvement. Overlaid
upon genetic selection one must be mindful of the epigen-
etic programming that environmental perturbations can
exert on future trait expression and how that may factor
into selection schemes for agricultural livestock production
in a changing environment. Better defined knowledge of
the mechanisms of programming will facilitate incorpor-
ation of epigenetic factors into selection.
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